2 in the Journal of Clinical Investigation. Squamous cell carcinoma is the second most common type of skin cancer. Physical removal of lesions on the skin does not reduce an individual's risk of ...
A new study uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first to activate specific components of the ...